IDX: CARE Statistics

Total Valuation

PT Metro Healthcare Indonesia Tbk has a market cap or net worth of IDR 5.99 trillion. The enterprise value is 6.40 trillion.

Market Cap	5.99T
Enterprise Value	6.40T

Important Dates

The next estimated earnings date is Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

PT Metro Healthcare Indonesia Tbk has 33.25 billion shares outstanding.

Current Share Class	n/a
Shares Outstanding	33.25B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	25.89%
Float	16.65B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.39
PB Ratio	1.98
P/TBV Ratio	1.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-71.56
EV / Sales	20.72
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-50.21

Financial Position

The company has a current ratio of 0.64, with a Debt / Equity ratio of 0.30.

Current Ratio	0.64
Quick Ratio	0.63
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	-7.25
Interest Coverage	-0.40

Financial Efficiency

Return on equity (ROE) is -2.90% and return on invested capital (ROIC) is -0.43%.

Return on Equity (ROE)	-2.90%
Return on Assets (ROA)	-0.43%
Return on Capital (ROIC)	-0.43%
Revenue Per Employee	384.93M
Profits Per Employee	-111.45M
Employee Count	742
Asset Turnover	0.08
Inventory Turnover	47.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.88% in the last 52 weeks. The beta is -0.38, so PT Metro Healthcare Indonesia Tbk's price volatility has been lower than the market average.

Beta (5Y)	-0.38
52-Week Price Change	+16.88%
50-Day Moving Average	147.48
200-Day Moving Average	120.53
Relative Strength Index (RSI)	70.57
Average Volume (20 Days)	42,272,010

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PT Metro Healthcare Indonesia Tbk had revenue of IDR 308.72 billion and -89.39 billion in losses. Loss per share was -2.69.

Revenue	308.72B
Gross Profit	98.95B
Operating Income	-27.87B
Pretax Income	-83.95B
Net Income	-89.39B
EBITDA	-4.46B
EBIT	-27.87B
Loss Per Share	-2.69

Full Income Statement

Balance Sheet

The company has 513.13 billion in cash and 923.40 billion in debt, giving a net cash position of -410.27 billion or -12.34 per share.

Cash & Cash Equivalents	513.13B
Total Debt	923.40B
Net Cash	-410.27B
Net Cash Per Share	-12.34
Equity (Book Value)	3.03T
Book Value Per Share	91.04
Working Capital	-313.10B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -85.84 billion and capital expenditures -41.55 billion, giving a free cash flow of -127.39 billion.

Operating Cash Flow	-85.84B
Capital Expenditures	-41.55B
Free Cash Flow	-127.39B
FCF Per Share	-3.83

Full Cash Flow Statement

Margins

Gross margin is 32.05%, with operating and profit margins of -9.03% and -28.95%.

Gross Margin	32.05%
Operating Margin	-9.03%
Pretax Margin	-27.19%
Profit Margin	-28.95%
EBITDA Margin	-1.44%
EBIT Margin	-9.03%
FCF Margin	n/a

Dividends & Yields

PT Metro Healthcare Indonesia Tbk does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1.49%
FCF Yield	-2.13%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PT Metro Healthcare Indonesia Tbk has an Altman Z-Score of 2.53. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.53
Piotroski F-Score	n/a